Sectors
BRNS
Barinthus Biotherapeutics plc
0.64
3 x 0.42
3 x 0.86
bid
ask
+
0.03
4.95%
09:14 AM
timesize
| Ytd | -9.14% | |
| 1y | -67.71% |
0.60
day range
0.60
0.51
52 week range
2.01
| Open | 0.60 | Prev Close | 0.61 | Low | 0.60 | High | 0.60 | Mkt Cap | 24.76M |
| Vol | 1.83K | Avg Vol | 72.48K | EPS | -1.29 | P/E | -0.47 | Forward P/E | -0.62 |
| Beta | -0.41 | Short Ratio | 0.19 | Inst. Own | 46.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 0.67 | 200-d Avg | 0.76 | 1yr Est | 7.25 |
| Income Statement | |||
| Operating Expenses | 6.08M | ||
| Research and Development Expense | 3.59M | ||
| Selling, General and Administrative Expense | 2.53M | ||
| Operating Income | -6.07M | ||
| Interest Expense | 13.00K | ||
| Income Tax Expense | -16.00K | ||
| Net Income | -5.53M | ||
| Net Income Common Stock | -5.53M | ||
| Net Income Common Stock (USD) | -5.53M | ||
| Consolidated Income | -5.53M | ||
| Net Income to Non-Controlling Interests | -3.00K | ||
| Earnings per Basic Share | -0.14 | ||
| Earnings per Basic Share (USD) | -0.14 | ||
| Earnings per Diluted Share | -0.14 | ||
| Earning Before Interest & Taxes (EBIT) | -5.53M | ||
| Earning Before Interest & Taxes (USD) | -5.53M | ||
| Weighted Average Shares | 40.85M | ||
| Weighted Average Shares Diluted | 40.85M | ||
| Balance Sheet | |||
| Cash and Equivalents | 67.19M | ||
| Cash and Equivalents (USD) | 67.19M | ||
| Current Assets | 72.66M | ||
| Property, Plant & Equipment Net | 4.90M | ||
| Total Assets | 92.14M | ||
| Debt Current | 2.01M | ||
| Total Debt | 11.01M | ||
| Current Liabilities | 12.00M | ||
| Debt Non-Current | 9.00M | ||
| Total Liabilities | 25.67M | ||
| Accumulated Retained Earnings (Deficit) | -309.63M | ||
| Accumulated Other Comprehensive Income | -18.56M | ||
| Shareholders Equity | 66.40M | ||
| Shareholders Equity (USD) | 66.40M | ||
| Assets Non-Current | 19.48M | ||
| Total Debt (USD) | 11.01M | ||
| Deferred Revenue | 318.00K | ||
| Goodwill and Intangible Assets | 13.67M | ||
| Liabilities Non-Current | 13.66M | ||
| Trade and Non-Trade Payables | 993.00K | ||
| Tax Assets | 1.23M | ||
| Tax Liabilities | 237.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.07M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.66M | ||
| Capital Expenditure | 55.00K | ||
| Net Cash Flow from Investing | 55.00K | ||
| Net Cash Flow from Operations | -3.37M | ||
| Effect of Exchange Rate Changes on Cash | -1.35M | ||
| Share Based Compensation | 556.00K | ||